Literature DB >> 20445160

Impact of pulmonary system limitations on locomotor muscle fatigue in patients with COPD.

Markus Amann1, Mark S Regan, Majd Kobitary, Marlowe W Eldridge, Urs Boutellier, David F Pegelow, Jerome A Dempsey.   

Abstract

We examined the effects of respiratory muscle work [inspiratory (W(r-insp)); expiratory (W(<span class="Chemical">r-exp))] and arterial oxygenation (Sp(O(2))) on exercise-induced locomotor muscle fatigue in patients with chronic obstructive pulmonary disease (COPD). Eight patients (FEV, 48 +/- 4%) performed constant-load cycling to exhaustion (Ctrl; 9.8 +/- 1.2 min). In subsequent trials, the identical exercise was repeated with 1) proportional assist ventilation + heliox (PAV); 2) heliox (He:21% O(2)); 3) 60% O(2) inspirate (hyperoxia); or 4) hyperoxic heliox mixture (He:40% O(2)). Five age-matched healthy control subjects performed Ctrl exercise at the same relative workload but for 14.7 min ( approximately best COPD performance). Exercise-induced quadriceps fatigue was assessed via changes in quadriceps twitch force (Q(tw,pot)) from before to 10 min after exercise in response to supramaximal femoral nerve stimulation. During Ctrl, absolute workload (124 +/- 6 vs. 62 +/- 7 W), W(r-insp) (207 +/- 18 vs. 301 +/- 37 cmH(2)O x s x min(-1)), W(r-exp) (172 +/- 15 vs. 635 +/- 58 cmH(2)O x s x min(-1)), and Sp(O(2)) (96 +/- 1% vs. 87 +/- 3%) differed between control subjects and patients. Various interventions altered W(r-insp), W(r-exp), and Sp(O(2)) from Ctrl (PAV: -55 +/- 5%, -21 +/- 7%, +6 +/- 2%; He:21% O(2): -16 +/- 2%, -25 +/- 5%, +4 +/- 1%; hyperoxia: -11 +/- 2%, -17 +/- 4%, +16 +/- 4%; He:40% O(2): -22 +/- 2%, -27 +/- 6%, +15 +/- 4%). Ten minutes after Ctrl exercise, Q(tw,pot) was reduced by 25 +/- 2% (P < 0.01) in all COPD and 2 +/- 1% (P = 0.07) in healthy control subjects. In COPD, DeltaQ(tw,pot) was attenuated by one-third after each interventional trial; however, most of the exercise-induced reductions in Q(tw,pot) remained. Our findings suggest that the high susceptibility to locomotor muscle fatigue in patients with COPD is in part attributable to insufficient O(2) transport as a consequence of exaggerated arterial hypoxemia and/or excessive respiratory muscle work but also support a critical role for the well-known altered intrinsic muscle characteristics in these patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20445160      PMCID: PMC2904150          DOI: 10.1152/ajpregu.00183.2010

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  69 in total

1.  Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD.

Authors:  F Maltais; P LeBlanc; F Whittom; C Simard; K Marquis; M Bélanger; M J Breton; J Jobin
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

2.  Effects of oxygen on lower limb blood flow and O2 uptake during exercise in COPD.

Authors:  F Maltais; M Simon; J Jobin; M Desmeules; M J Sullivan; M Bélanger; P Leblanc
Journal:  Med Sci Sports Exerc       Date:  2001-06       Impact factor: 5.411

3.  Expiratory threshold loading impairs cardiovascular function in health and chronic heart failure during submaximal exercise.

Authors:  Jordan D Miller; Sarah J Hemauer; Curtis A Smith; Michael K Stickland; Jerome A Dempsey
Journal:  J Appl Physiol (1985)       Date:  2006-03-30

4.  Respiratory muscle activity in patients with COPD walking to exhaustion with and without pressure support.

Authors:  D Kyroussis; M I Polkey; C H Hamnegård; G H Mills; M Green; J Moxham
Journal:  Eur Respir J       Date:  2000-04       Impact factor: 16.671

5.  Effect of exercise-induced arterial hypoxemia on quadriceps muscle fatigue in healthy humans.

Authors:  Lee M Romer; Hans C Haverkamp; Andrew T Lovering; David F Pegelow; Jerome A Dempsey
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-09-15       Impact factor: 3.619

6.  Limitation of lower limb VO(2) during cycling exercise in COPD patients.

Authors:  M Simon; P LeBlanc; J Jobin; M Desmeules; M J Sullivan; F Maltais
Journal:  J Appl Physiol (1985)       Date:  2001-03

7.  Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD.

Authors:  Denis E O'Donnell; Alan L Hamilton; Katherine A Webb
Journal:  J Appl Physiol (1985)       Date:  2006-05-04

8.  Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease.

Authors:  D E O'Donnell; C D'Arsigny; K A Webb
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

Review 9.  Consequences of exercise-induced respiratory muscle work.

Authors:  Jerome A Dempsey; Lee Romer; Joshua Rodman; Jordan Miller; Curtis Smith
Journal:  Respir Physiol Neurobiol       Date:  2006-04-28       Impact factor: 1.931

10.  Effects of arterial oxygen content on peripheral locomotor muscle fatigue.

Authors:  Markus Amann; Lee M Romer; David F Pegelow; Anthony J Jacques; C Joel Hess; Jerome A Dempsey
Journal:  J Appl Physiol (1985)       Date:  2006-02-23
View more
  34 in total

1.  Cardiorespiratory responses to exercise in CHF: a conspiracy of maladaptation.

Authors:  Jerome A Dempsey
Journal:  J Physiol       Date:  2010-08-01       Impact factor: 5.182

2.  Quadriceps exercise intolerance in patients with chronic obstructive pulmonary disease: the potential role of altered skeletal muscle mitochondrial respiration.

Authors:  Jayson R Gifford; Joel D Trinity; Gwenael Layec; Ryan S Garten; Song-Young Park; Matthew J Rossman; Steen Larsen; Flemming Dela; Russell S Richardson
Journal:  J Appl Physiol (1985)       Date:  2015-08-13

3.  Passive leg movement in chronic obstructive pulmonary disease: evidence of locomotor muscle vascular dysfunction.

Authors:  Stephen J Ives; Gwenael Layec; Corey R Hart; Joel D Trinity; Jayson R Gifford; Ryan S Garten; Melissa A H Witman; Jacob R Sorensen; Russell S Richardson
Journal:  J Appl Physiol (1985)       Date:  2020-04-23

Review 4.  Pathophysiology of human ventilatory control.

Authors:  Jerome A Dempsey; Curtis A Smith
Journal:  Eur Respir J       Date:  2014-06-12       Impact factor: 16.671

Review 5.  An integrated view on the oxygenation responses to incremental exercise at the brain, the locomotor and respiratory muscles.

Authors:  Jan Boone; Kristof Vandekerckhove; Ilse Coomans; Fabrice Prieur; Jan G Bourgois
Journal:  Eur J Appl Physiol       Date:  2016-09-09       Impact factor: 3.078

6.  Is the healthy respiratory system built just right, overbuilt, or underbuilt to meet the demands imposed by exercise?

Authors:  Jerome A Dempsey; Andre La Gerche; James H Hull
Journal:  J Appl Physiol (1985)       Date:  2020-08-13

7.  New device for nonvolitional evaluation of quadriceps force in ventilated patients.

Authors:  Franco Laghi; Najeeb Khan; Thimothy Schnell; Dinas Aleksonis; Kendra Hammond; Hameeda Shaikh; Eileen Collins; Amal Jubran; Martin J Tobin
Journal:  Muscle Nerve       Date:  2017-12-11       Impact factor: 3.217

8.  Determinants of the diminished exercise capacity in patients with chronic obstructive pulmonary disease: looking beyond the lungs.

Authors:  Ryan M Broxterman; Jan Hoff; Peter D Wagner; Russell S Richardson
Journal:  J Physiol       Date:  2020-01-19       Impact factor: 5.182

9.  Oral antioxidants improve leg blood flow during exercise in patients with chronic obstructive pulmonary disease.

Authors:  Matthew J Rossman; Joel D Trinity; Ryan S Garten; Stephen J Ives; Jamie D Conklin; Zachary Barrett-O'Keefe; Melissa A H Witman; Amber D Bledsoe; David E Morgan; Sean Runnels; Van R Reese; Jia Zhao; Markus Amann; D Walter Wray; Russell S Richardson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-17       Impact factor: 4.733

10.  Impact of fatigue in patients with chronic obstructive pulmonary disease: results from an exploratory study.

Authors:  Sabina Antonela Antoniu; Elena Petrescu; Raluca Stanescu; Ecaterina Anisie; Lucian Boiculese
Journal:  Ther Adv Respir Dis       Date:  2015-11-22       Impact factor: 4.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.